This work describes the development of sideroblastic anemia (SA) during the clinical activity of systemic lupus erythematosus (SLE) in two patients. The cases refer to two women with SLE who developed SA during a relapse of the illness. Both patients fulfilled at least four criteria of the American Association of Rheumatology for SLE. In one patient, the treatment with prednisone was followed by the resolution of the SLE activity and the disappearance of the SA. Several years later there was no evidence of ringed sideroblasts or malignancy in the bone marrow. In the other patient, the clinical activity of the SLE and SA developed during the beginning of a septicemic event which finally led to her death.
Our clinical cases allow us to show that the transitory development of SA can occur during a period of clinical activity of SLE and that its association, although infrequent, is due to a common physiopathogenic mechanism.
Bennet JM, Catovsky D., Daniel MT et al. Proposals for the classification of the myelodysplastic syndromes . Br J Haematol1982; 51: 189-99.
3.
Stark AN, Scott CS, Bhatt B., Roberts B.Myelodysplastic syndrome coexisting with acute lymphoblastic leukemia . J Clin Pathol1986; 39: 728-30.
4.
George SW, Newman EDSeronegative inflammatory arthritis in the myelodysplastic syndromes . Sem Arthritis Rheum1992; 21: 345-54.
5.
Sacher RA, McGinnis MM, Shashaty G. et al. The occurrence of an autoimmune hemolytic anemia with anti-U specificity in a patient with myelodysplastic syndrome. Am J Clin Pathol1982; 77: 356-9.
6.
Mita M., Sato T., Matsuda S. et al. Immunological abnormalities in myelodysplastic syndromes. Three cases with positive direct Coomb's test. Rinsho Ketsueki1987; 28: 713-20.
DeCoteau WE, Katakkar SB, Skinnider L. et al. Sjögren terminating as a myeloproliferative disorder. J Rheumatol1975; 2: 331-5.
9.
Bellas SKSideroblastic refractory anemia in a patient with systemic lupus erythematosus (case report). Am J Med Sci1973; 265: 225-31.
10.
Nakayama S. , Nakamura F., Yabe H. et al. Systemic lupus erythematosus in a patient with refractory anemia. Nippon KetsuekiGakkai Zasshi1989; 52: 1072-7.
11.
Ng HS, Ng HW, Sinniah R., Feng PHA case of systemic lupus erythematosus with sideroblastic anemia terminating in erythroleukemia. Ann Rheum Dis1981; 40: 422-6.
12.
Green AR, Shuttleworth D., Bowen DT, Bentley DPCutaneous vasculitis in patients with myelodysplasia. Br J Haematol1990; 74: 364-70.
13.
EngCh, Farraye FA, Schulman LN, Peppercorn MA, Krauss CM, Connors JM, Stone RM. The association between the myelodysplastic syndromes and Crohn's disease . Ann Intern Med1992; 117: 661-2.
14.
Castro M., Conn DL, Daniel Su WP, Garton JPRheumatic manifestations in myelodysplastic syndromes. J Rheumatol1991; 18: 721-7.
Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum1982; 25: 1271-7.
17.
Deaton JG, Levin WCSystemic lupus erythematosus and acute myeloblastic leukemia: report of their coexistence and a survey of possible associating features. Arch Intern Med1967; 120: 345-8.
18.
Watanabe Duffy KN, Duffy CM, Gladman DDInfection and disease activity in systemic lupus erythematosus: a review of hospitalized patients . J Rheumatol199 1; 18:1180-4.
19.
Schreiber ZA , Schwartz JM, Joseph A.Reversible sideroblastic anemia in the course of bacterial infection. Blood1971; 38: 837 (abstract 152).
20.
Hamblin T.Immunologic abnormalities in myelodysplastic syndromes. Hematol Oncol Clin North Am1992; 6: 571-85.
21.
Laurence J. , Nachman R.Hematologic aspects of systemic lupus erythematosus . In: Systemic Lupus ErythematosusLahita RG (ed.). New York: Wiley, 1978: 721-89.
